UB

Uma Balijepalli

Director Director DIN 03642071
DIN 03642071 First appointment Jan 2012 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jan 2012
Shareholding value Locked Premium profile

About Uma Balijepalli

Uma Balijepalli has 14 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 03642071
Primary Designation Director
First Appointment 03 Jan 2012
Oldest Company Age 14 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Usg Pharmaceuticals India Private Limited U24239TG2012PTC078375
Director 03 Jan 2012 2012 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Usg Pharmaceuticals India Private Limited
Premium access

Shareholding and investment profile for Uma Balijepalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Uma Balijepalli

Uma Balijepalli has 14 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Uma Balijepalli is associated with 0 companies as Director.

Uma Balijepalli has expertise in General Business.

Uma Balijepalli has 14 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available